ClinicalTrials.gov
public full text
Public Domain
Early Use of Hyperimmune Plasma in COVID-19
The study assesses the efficacy of early administration of hyperimmune plasma in covid-19 patients who are on CPAP or intubated. Efficacy is measured as a 2 point decrease in the WHO scale
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals#873616
- Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China#369863
- Mast Cells in Acute COVID ‐19 Patients#145038
- Determinants of COVID-19 and non-COVID-19 vaccine confidence in lowand middle-income countries: A systematic review of qualitative evidence and thematic synthesis#443474
- UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)#845087
Record · ID 1410673
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive